Positions 51–62 of 62.
Thinking out loud about this: appetite return — my 20-week log, condensed into one table. Went back on after eight months away. Nobody here made me feel bad about it,…
reading regain threads from 2024 and half of it aged badly — a position I have arrived at slowly and would like tested. Preparing to stop, as described by people here…
switched from 0.5mg to 1.0mg and early fullness got better, not worse. Not a hot take, just something I have not seen said plainly here. 0.5mg and 1.0mg. Those are…
Trying to get a straight answer on this: someone explain interval stretching to me like I have not read a paper in years. A written baseline — dose, date, weight,…
Reference standards, analytical reagents and system-suitability material. If you are running your own method, start with a known.
Reference standardsCheck-in as promised in the title: 23 months in and interval stretching is still the thing I get wrong. The relevant figures are 23 months, and they come from the same…
Something I keep coming back to: unpopular opinion: most of what gets said here about discontinuation is guesswork. Stretched from seven days to ten to twelve over four…
Reporting in. 15 weeks on 0.25mg, full numbers, ask me anything boring. 15 weeks and 0.25mg. Those are measured, not estimated, and not rounded up in my favour.…
Posting this as a discussion rather than a claim: we are measuring regain at the wrong time and calling it noise. Preparing to stop, as described by people here who…
Thinking out loud about this: three years of appetite return threads, summarised so you do not have to read them. Went back on after eight months away. Nobody here made…
discontinuation is doing more work than we give it credit for — a position I have arrived at slowly and would like tested. Regained most of it over a year and spent…
the interval stretching thing finally clicked for me and I want to write it down — a position I have arrived at slowly and would like tested. Regained most of it over a…
discontinuation — my 15-week log, condensed into one table. It is the sort of thing everyone half-believes and nobody writes down. Stopped for cost reasons. Appetite…
Stopping on purpose: dose reduction versus interval stretching, what the discontinuation arms of STEP 1 and SURMOUNT-4 actually showed about regain, appetite return timelines, and the people who came off, regained, and went back on without treating it as a failure.
Independent testing plus vendor-level trend data. Community-funded, unaffiliated.
peptidemeter.comSeveral compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.
Reference